Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Problems with FDA Medical Device Approval Process Identified in New Studies December 30, 2009 AboutLawsuits Add Your Comments Two new studies have been published that are highly critical of the way the FDA approves medical devices for human use, saying that the agency requires too few clinical trials, and that often the data in those trials is suspect. The new studies come as the FDA is under increasing scrutiny over how it decides which medical devices, such as pacemakers and stents, can be implanted in human beings. One study, conducted by researchers from the University of California and published this week in the Journal of the American Medical Association, found that two thirds of approved devices only went through one clinical trial before being unleashed on the market, and most of those trials involved less than 300 subjects. The other study, conducted by researchers from the FDA and Boston’s Beth Israel Deaconess Medical Center, will be published in the upcoming issue of the American Journal of Therapeutics, indicating that about 40% of the studies used to decide what devices are approved lack clear definitions of safety requirements. The stakes in FDA’s medical device approval process are high following a 2008 Supreme Court decision in Riegel vs. Medtronic which determined that FDA approval can make medical device manufacturers immune from lawsuits for injuries caused by defective medical devices. As a consequence of that decision, thousands of pending medical device lawsuits have been dismissed, including cases filed on behalf of thousands of patients injured by the recalled Medtronic Sprint Fidelis defibrillator lead. Although the design of the Medtronic lead makes it prone to fracture or break, a federal judge ruled earlier this year that patient claims for medical expenses and other compensation are now barred because the FDA approved the device. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION “Premarket approval of cardiovascular devices by the FDA is often based on studies that lack adequate strength and may be prone to bias,” concluded the University of California researchers. They came to that finding after a review of 123 summaries of safety and effectiveness data for 78 high-risk cardiovascular devices approved from 2000 through 2007. The review found that 65% of the devices were approved after only one study, and 78% of the total number of studies had discrepancies between the number of patients enrolled and the number that was actually analyzed. FDA officials have faulted the study for comparing the way medical devices are approved to the way drugs are approved, but the researchers say that the stakes are higher for medical devices, since patients can stop using drugs but dealing with faulty medical devices implanted in the body is a much more complex process. Industry officials say the researchers did not have access to all of the data provided to the FDA. In the FDA and Beth Israel study, researchers found that the FDA used poorly defined safety and effectiveness goals, and studies had poor patient accounting, incomplete collection of patient information, and determined that the studies being conducted lacked representation by women, nonwhite populations and children. “Manufacturers, regulators, and the clinical community should collaborate to address these study shortcomings to ensure that patients are treated with reliable, safe, and clinically useful medical devices,” researchers from that study concluded. Since the Supreme Court ruling a number of agencies and studies have been focused on whether the FDA can actually carry the entire burden of being responsible for medical device safety. Uniformly, those studies have found the agency’s approval process lacking. This summer the Government Accountability Office (GAO) released a report that highlighted how FDA oversight of medical devices is inadequate, arguing that they are not an effective guardian of patient safety. Congress is currently considering a bill called the Medical Device Safety Act of 2009, which seeks to clarify that FDA approval does not preempt lawsuits against medical device manufacturers, overturning the Supreme Court ruling. Opponents of the legislation say that enacting the Medical Device Safety Act of 2009 would stifle innovation and cannot be a substitute for strengthening the FDA. Tags: Defibrillator Lead, Medical Device, Medtronic, Product Liability, Sprint Fidelis More Lawsuit Stories Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser May 9, 2025 First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks May 9, 2025 Phthalates Linked to More Than 350,000 Deaths Worldwide Each Year: Study May 9, 2025 4 Comments KAREN January 21, 2010 THE FDA HAS BEEN PROVEN OVER AND OVER AGAIN TO BE HAINIOUSLY NEGLIGENT TO THE AMERICAN CONSUMERS WELLFAIR. FROM UNETHICAL MONETARY COMPENSATION, STOCK COMPENSATION, LAVUOS GIFTS FOR PHYSICIANS AND TO SOME FDA EMPLOYEES UPON RECEIVING THE FDA’S APPROVAL. FROM RECALLED DOG FOOD, TOOTHPASTE, LEAD POISONING IN OUR CHILDRENS TOYS AND MOST DIFFINITELY IN THE MEDICAL PRODUCT AND DRUG INDUSTRY. WHEN DO YOU TURN ON YOUR TELEVISION AND NOT SEE THE ADVERTISEMENTS FOR MEDICAL AND DRUG PRODUCT DEFECTS AND RECALLS….. ALL OF YOU WHO HAVE BEEN INJURED HAVE BEEN VICTIMS OF THIS NEGLIGENCE….. SYNTHES /SPINE SOLUTION PRODUCT “PRODISC L” HAS AFFECTED MANY OF YOU DUE TO PRODUCT DEFECT. BUT YET IT HAS MET THE SO CALLED FDA APPROVAL AND THEY (OUR FDA) WEREN’T EVEN AWARE OF ALL THE PRE-TRIAL RESULTS AND FINANCIAL GAIN TO THE PHYSICIANS UPON GAINING THE THE “FDA’S” APPROVAL. IF WE DON’T GIVE CONTROL BACK TO THE CONSUMERS THE RIGHT TO SUE DUE TO FAULTY MEDICAL OR DRUG PRODUCTS OR USAFE COMMODITIES THROUGH THE MEDICAL DEVICE SAFETY ACT …WE WON’T NEED TO WORRY ABOUT HEALTHCARE REFORM… WHO’S GOING TO TRUST OUR GOVERNMENT TO PROTECT US IF WE ALLOW THEM TO BE IMMUNED FOR THEIR NEGLIGENCE OR UNETHICAL PRACTICES…….OR IS THIS REALLY PART OF THEIR AGENDA? dkrause January 4, 2010 The opposite is also true. The FDA holds devices in a category too long which hinder competition. A class 3 device should have limited time frame to alow other manufacturers produce and compete. FDA allows manufacturer (s) to monopolize market. Peter December 30, 2009 Life Support Medical Devices, Sense, Pace, Rapid Pace, Shock.. Abiility to Pace via fully implantable devices has been studied/evaluated for nearly 50 years (Berkovits Research, Boston. Includes waveform use in Lown Cardioverter) “Sense” (R.Terry/W.Keller) near 45 years of success in all cardiac waveforn identification. “Shock” (B. Lown Boston) fully implantable 30+years. “Designs” goals=reliability, efficient use of available power, size. “Materials” (Nobel encasements). military grade components, “Functions” driven by Physican input.(Yes, some are highly paid consultants) from field studies. Class I Recalls have mostly been the result of component compromise not any intentional behavior or lack of quality control by Manufacturers. Tort /FDA only adds cost. But the two really creats jobs. Shari December 30, 2009 The FDA not only approves medical devices without adequate test and research data, they also approve drugs that are ineffective for their intended purpose and that have dangerous side effects. The generic drug for IMITREX (Dr Reddy’s Sumatriptan) is absolute ineffective and the side effects include muscle weakness that will leave an individual unable to stand alone or walk. The nausea associate with migraine headaches necessitates the need to ambulate and get to a bathroom quickly. The drug can leave an unsuspecting person in very dangerous position with the possibility of serious injury from falls when they attempt this and are unable to walk. Not to mention that one will also be left in sever pain from the ineffectiveness of the drug. You can’t even get in your car to go the emergency room for care due to the serious side effects so you are just left to suffer with the intense pain of migraine pain unless you are fortunate enough to have someone come to care for you. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (Posted: 2 days ago) A hairdresser who has worked for nearly 40 years in the industry says her constant exposure to hair dye led to a bladder cancer diagnosis. MORE ABOUT: HAIR DYE LAWSUITSalon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)Hair Dye Cancer Lawsuit Filed Over Wrongful Death of Salon Professional (04/11/2025) First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (Posted: 2 days ago) An Oxbryta class action lawsuit has been scheduled for trial in August 2027, but must first survive a motion to dismiss filed by manufacturers. MORE ABOUT: OXBRYTA LAWSUITMalpractice Lawsuit Alleges Side Effects of Oxbryta Caused Untimely Death (04/15/2025)At Least 8 Lawsuits Over Oxbryta Filed Against Pfizer, Global Blood Therapeutics (03/14/2025)After Recalling Oxbryta, Pfizer Seeks Dismissal of Class Action Brought by Former Users (03/07/2025) Court Urged To Combine 5 AFFF Lawsuits For First MDL Bellwether Trial (Posted: 3 days ago) Plaintiffs have asked the judge presiding over all AFFF lawsuits to consolidate five claims involving kidney cancer and testicular cancer injuries for the first bellwether trial in the federal MDL. MORE ABOUT: AFFF LAWSUITAdditional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (04/29/2025)Firefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)
Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser May 9, 2025
Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (Posted: 2 days ago) A hairdresser who has worked for nearly 40 years in the industry says her constant exposure to hair dye led to a bladder cancer diagnosis. MORE ABOUT: HAIR DYE LAWSUITSalon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)Hair Dye Cancer Lawsuit Filed Over Wrongful Death of Salon Professional (04/11/2025)
First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (Posted: 2 days ago) An Oxbryta class action lawsuit has been scheduled for trial in August 2027, but must first survive a motion to dismiss filed by manufacturers. MORE ABOUT: OXBRYTA LAWSUITMalpractice Lawsuit Alleges Side Effects of Oxbryta Caused Untimely Death (04/15/2025)At Least 8 Lawsuits Over Oxbryta Filed Against Pfizer, Global Blood Therapeutics (03/14/2025)After Recalling Oxbryta, Pfizer Seeks Dismissal of Class Action Brought by Former Users (03/07/2025)
Court Urged To Combine 5 AFFF Lawsuits For First MDL Bellwether Trial (Posted: 3 days ago) Plaintiffs have asked the judge presiding over all AFFF lawsuits to consolidate five claims involving kidney cancer and testicular cancer injuries for the first bellwether trial in the federal MDL. MORE ABOUT: AFFF LAWSUITAdditional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (04/29/2025)Firefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)